Tech Company Financing Transactions
Visterra Funding Round
On 10/6/2017, Visterra raised $46.7 million in Series C funding from Alexandria Venture Investments, Allegheny Financial Group and Bill & Melinda Gates Foundation.
Transaction Overview
Company Name
Announced On
10/6/2017
Transaction Type
Venture Equity
Amount
$46,700,000
Round
Series C
Investors
Proceeds Purpose
A majority of the proceeds from the Series C financing have and will be used to prepare for a planned Phase 2b c'inical trial for Visterra's lead product candidate, VIS410, an antibody in development for the treatment of hospitalized patients with influenza A, regardless of the viral strain, and to advance VIS649, an antibody in development for the treatment of IgA nephropathy that has demonstrated promising results in animal models, to a Phase 1 clinical trial.
Company Information
Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
275 2nd Ave.
Waltham, MA 02451
USA
Waltham, MA 02451
USA
Phone
Website
Email Address
Overview
Visterra, Inc. is dedicated to the discovery and development of innovative products for the prevention, treatment and diagnosis of infectious diseases. The Company focuses on technologies that can interrogate how pathogens interact with human cells, a critical first step in the disease process.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Brian Pereira
Chief Scientific Officer
Zachary Shriver
Vice President
Jean Bender
VP - Administration
Chris Kiefer
VP - Bus. Development
Greg Miller
VP - Finance
Todd Curtis
VP - R & D
Greg Babcock
Browse more venture capital transactions:
Prev: 10/6/2017: Stellar Labs venture capital transaction
Next: 10/6/2017: MemberSuite venture capital transaction
Share this article
About Our VC Transactions Data
We record every notable VC transaction. VC investment data records reported here are sourced from publicly available VC deal announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs